Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board

Decoy Therapeutics appointed co-founder Brad Pentelute, MIT Professor of Chemistry, as Chair of its Scientific Advisory Board. Pentelute replaces Shahin Gharakhanian, who served as SAB Chair during the company's foundational period and will remain a partner.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.